| Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) MW Sereda, G Meyer zu Hörste, U Suter, N Uzma, KA Nave Nature medicine 9 (12), 1533-1537, 2003 | 378 | 2003 |
| CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity C Wang, N Yosef, J Gaublomme, C Wu, Y Lee, CB Clish, J Kaminski, ... Cell 163 (6), 1413-1427, 2015 | 377 | 2015 |
| Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis D Schafflick, CA Xu, M Hartlehnert, M Cole, A Schulte-Mecklenbeck, ... Nature communications 11 (1), 247, 2020 | 275 | 2020 |
| Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity PR Burkett, GM zu Horste, VK Kuchroo The Journal of clinical investigation 125 (6), 2211-2219, 2015 | 265 | 2015 |
| Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy G Meyer zu Horste, T Prukop, D Liebetanz, W Mobius, KA Nave, ... Annals of neurology 61 (1), 61-72, 2007 | 173 | 2007 |
| Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid M Heming, X Li, S Räuber, AK Mausberg, AL Börsch, M Hartlehnert, ... Immunity 54 (1), 164-175. e6, 2021 | 142 | 2021 |
| From bench to bedside—experimental rationale for immune-specific therapies in the inflamed peripheral nerve G Meyer zu Hörste, HP Hartung, BC Kieseier Nature clinical practice Neurology 3 (4), 198-211, 2007 | 127 | 2007 |
| RBPJ controls development of pathogenic Th17 cells by regulating IL-23 receptor expression GM Zu Horste, C Wu, C Wang, L Cong, M Pawlak, Y Lee, W Elyaman, ... Cell reports 16 (2), 392-404, 2016 | 115 | 2016 |
| Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity A Schnell, L Huang, M Singer, A Singaraju, RM Barilla, BML Regan, ... Cell 184 (26), 6281-6298. e23, 2021 | 113 | 2021 |
| Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges D Schafflick, J Wolbert, M Heming, C Thomas, M Hartlehnert, AL Börsch, ... Nature neuroscience 24 (9), 1225-1234, 2021 | 112 | 2021 |
| Immune cell activation in the cerebrospinal fluid of patients with Parkinson's disease JB Schröder, M Pawlowski, G Meyer zu Hörste, CC Gross, H Wiendl, ... Frontiers in neurology 9, 424107, 2018 | 109 | 2018 |
| Review of teriflunomide and its potential in the treatment of multiple sclerosis C Warnke, G Meyer zu Hörste, HP Hartung, O Stüve, BC Kieseier Neuropsychiatric disease and treatment, 333-340, 2009 | 108 | 2009 |
| The immunocompetence of Schwann cells G Meyer Zu Hörste, W Hu, HP Hartung, HC Lehmann, BC Kieseier Muscle & Nerve: Official Journal of the American Association of …, 2008 | 108 | 2008 |
| Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type … A Leal, K Huehne, F Bauer, H Sticht, P Berger, U Suter, B Morera, ... neurogenetics 10, 275-287, 2009 | 107 | 2009 |
| Charcot–Marie–Tooth disease CMT4A: GDAP1 increases cellular glutathione and the mitochondrial membrane potential R Noack, S Frede, P Albrecht, N Henke, A Pfeiffer, K Knoll, T Dehmel, ... Human molecular genetics 21 (1), 150-162, 2012 | 106 | 2012 |
| Redefining the heterogeneity of peripheral nerve cells in health and autoimmunity J Wolbert, X Li, M Heming, AK Mausberg, D Akkermann, C Frydrychowicz, ... Proceedings of the National Academy of Sciences 117 (17), 9466-9476, 2020 | 97 | 2020 |
| Loss of IL-10 promotes differentiation of microglia to a M1 phenotype B Laffer, D Bauer, S Wasmuth, M Busch, TV Jalilvand, S Thanos, ... Frontiers in cellular neuroscience 13, 430, 2019 | 90 | 2019 |
| Animal models of inherited neuropathies GM Zu Hörste, KA Nave Current opinion in neurology 19 (5), 464-473, 2006 | 81 | 2006 |
| Recovery of the T-cell repertoire in CIDP by IV immunoglobulins AK Mausberg, M Dorok, M Stettner, M Müller, HP Hartung, T Dehmel, ... Neurology 80 (3), 296-303, 2013 | 69 | 2013 |
| A rat model of Charcot–Marie–Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients R Fledrich, B Schlotter-Weigel, TJ Schnizer, SP Wichert, RM Stassart, ... Brain 135 (1), 72-87, 2012 | 69 | 2012 |
Helmar LehmannUniversitätsklinik KölnVerified email at uk-koeln.de
